Sathyavani Subbarao

620 total citations
16 papers, 364 citations indexed

About

Sathyavani Subbarao is a scholar working on Infectious Diseases, Epidemiology and Health. According to data from OpenAlex, Sathyavani Subbarao has authored 16 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 6 papers in Epidemiology and 3 papers in Health. Recurrent topics in Sathyavani Subbarao's work include SARS-CoV-2 and COVID-19 Research (7 papers), COVID-19 Clinical Research Studies (4 papers) and COVID-19 epidemiological studies (3 papers). Sathyavani Subbarao is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (7 papers), COVID-19 Clinical Research Studies (4 papers) and COVID-19 epidemiological studies (3 papers). Sathyavani Subbarao collaborates with scholars based in United Kingdom, India and United States. Sathyavani Subbarao's co-authors include Paul Moss, Jamie Lopez Bernal, Mary Ramsay, Andrew Copas, Tom Palmer, Borscha Azmi, Laura Shallcross, Rebecca Giddings, Daniel Davies and Maria Krutikov and has published in prestigious journals such as Nature Communications, Scientific Reports and The Lancet Infectious Diseases.

In The Last Decade

Sathyavani Subbarao

15 papers receiving 359 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sathyavani Subbarao United Kingdom 9 225 116 115 69 33 16 364
Watsamon Jantarabenjakul Thailand 11 331 1.5× 80 0.7× 73 0.6× 44 0.6× 20 0.6× 53 449
Rebecca Giddings United Kingdom 8 229 1.0× 82 0.7× 116 1.0× 68 1.0× 20 0.6× 10 357
Sara De Nitto Italy 13 155 0.7× 235 2.0× 224 1.9× 35 0.5× 35 1.1× 20 373
Nicholas Brousseau Canada 12 189 0.8× 175 1.5× 236 2.1× 59 0.9× 48 1.5× 48 461
Robin Marlow United Kingdom 12 216 1.0× 75 0.6× 140 1.2× 31 0.4× 15 0.5× 38 417
Dorothea Matysiak‐Klose Germany 12 90 0.4× 111 1.0× 243 2.1× 20 0.3× 43 1.3× 32 347
Xinghuo Pang China 13 106 0.5× 108 0.9× 357 3.1× 45 0.7× 42 1.3× 34 445
Alla Heider Germany 10 127 0.6× 75 0.6× 378 3.3× 71 1.0× 60 1.8× 15 444
Hester Allen United Kingdom 10 250 1.1× 46 0.4× 61 0.5× 90 1.3× 12 0.4× 19 367
Meital Elbaz Israel 8 231 1.0× 73 0.6× 61 0.5× 30 0.4× 23 0.7× 16 330

Countries citing papers authored by Sathyavani Subbarao

Since Specialization
Citations

This map shows the geographic impact of Sathyavani Subbarao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sathyavani Subbarao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sathyavani Subbarao more than expected).

Fields of papers citing papers by Sathyavani Subbarao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sathyavani Subbarao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sathyavani Subbarao. The network helps show where Sathyavani Subbarao may publish in the future.

Co-authorship network of co-authors of Sathyavani Subbarao

This figure shows the co-authorship network connecting the top 25 collaborators of Sathyavani Subbarao. A scholar is included among the top collaborators of Sathyavani Subbarao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sathyavani Subbarao. Sathyavani Subbarao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Pallett, Scott J C, Esmita Charani, Andrea Mazzella, et al.. (2023). National action plans for antimicrobial resistance and variations in surveillance data platforms. Bulletin of the World Health Organization. 101(8). 501–512F. 13 indexed citations
2.
Subbarao, Sathyavani, Sonia Ribeiro, Helen Campbell, et al.. (2023). Trends in laboratory-confirmed bacterial meningitis (2012–2019): national observational study, England. The Lancet Regional Health - Europe. 32. 100692–100692. 5 indexed citations
3.
Paranthaman, Karthik, Sathyavani Subbarao, Nick Andrews, et al.. (2022). Effectiveness of BNT162b2 and ChAdOx-1 vaccines in residents of long-term care facilities in England using a time-varying proportional hazards model. Age and Ageing. 51(5). 6 indexed citations
4.
Amirthalingam, Gayatri, Jamie Lopez Bernal, Nick Andrews, et al.. (2021). Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England. Nature Communications. 12(1). 7217–7217. 66 indexed citations
5.
Subbarao, Sathyavani, Helen Campbell, Sonia Ribeiro, et al.. (2021). Invasive Meningococcal Disease, 2011–2020, and Impact of the COVID-19 Pandemic, England. Emerging infectious diseases. 27(9). 2495–2497. 18 indexed citations
6.
Shrotri, Madhumita, Maria Krutikov, Tom Palmer, et al.. (2021). Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study. The Lancet Infectious Diseases. 21(11). 1529–1538. 120 indexed citations
7.
Morgan, Caitlin, Jessica Barrett, Aaron Brown, et al.. (2021). Respiratory samples to diagnose tuberculosis in the absence of chest x-ray abnormalities. Respiratory Medicine. 185. 106488–106488.
8.
Shrotri, Madhumita, Maria Krutikov, Tom Palmer, et al.. (2021). Vaccine Effectiveness of the First Dose of ChAdox1 nCOV-19 and BNT162b2 Against SARS-CoV-2 Infection in Residents of Long Term Care Facilities (VIVALDI Study). SSRN Electronic Journal. 11 indexed citations
9.
Subbarao, Sathyavani, Lenesha Warrener, Katja Höschler, et al.. (2021). Robust antibody responses in 70–80-year-olds 3 weeks after the first or second doses of Pfizer/BioNTech COVID-19 vaccine, United Kingdom, January to February 2021. Eurosurveillance. 26(12). 25 indexed citations
10.
Subbarao, Sathyavani, Sonia Ribeiro, Helen Campbell, et al.. (2021). Trends in Laboratory-Confirmed Bacterial Meningitis (2012-2019): National Observational Study, England. SSRN Electronic Journal. 2 indexed citations
11.
Subbarao, Sathyavani, Lenesha Warrener, Katja Höschler, et al.. (2021). Robust Antibody Responses in 70-80 Year Olds following 1 or 2 Doses of Pfizer COVID-19 Vaccine. SSRN Electronic Journal. 1 indexed citations
13.
Subbarao, Sathyavani, Julia Sanchez‐Garrido, Nitya Krishnan, Avinash R. Shenoy, & Brian D. Robertson. (2020). Genetic and pharmacological inhibition of inflammasomes reduces the survival of Mycobacterium tuberculosis strains in macrophages. Scientific Reports. 10(1). 3709–3709. 19 indexed citations
14.
Subbarao, Sathyavani, Katalin A. Wilkinson, Tom Boyles, et al.. (2015). Raised Venous Lactate and Markers of Intestinal Translocation Are Associated With Mortality Among In-Patients With HIV-Associated TB in Rural South Africa. JAIDS Journal of Acquired Immune Deficiency Syndromes. 70(4). 406–413. 12 indexed citations
15.
Subbarao, Sathyavani, et al.. (2014). Cytomegalovirus proctitis mimicking rectal cancer in an immunocompetent elderly patient: a case report. BMC Research Notes. 7(1). 799–799. 2 indexed citations
16.
Lokeshwar, M. R., Anju Agrawal, Sathyavani Subbarao, et al.. (2000). Age related seroprevalence of antibodies to varicella in India.. PubMed. 37(7). 714–9. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026